Frontiers in Cellular and Infection Microbiology

Papers
(The H4-Index of Frontiers in Cellular and Infection Microbiology is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development550
Antibiotics as Major Disruptors of Gut Microbiota397
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields234
Role and Mechanism of Gut Microbiota in Human Disease219
Antibiotic Resistance: One Health One World Outlook218
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China199
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens196
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance178
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species167
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey160
SARS-COV-2 Variants: Differences and Potential of Immune Evasion151
The Female Vaginal Microbiome in Health and Bacterial Vaginosis138
Periodontal Disease: The Good, The Bad, and The Unknown129
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System127
The Gut Microbiota in Inflammatory Bowel Disease126
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria123
Wuhan to World: The COVID-19 Pandemic120
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression113
Urinary Microbiome: Yin and Yang of the Urinary Tract111
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine110
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome109
Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan100
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies100
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics99
Promising Therapeutic Strategies Against Microbial Biofilm Challenges98
Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives97
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy97
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro93
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities93
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia92
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases91
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease91
Gut Microbiota and Diarrhea: An Updated Review90
Chitosan-Based Nanoparticles Against Viral Infections89
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus89
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection89
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance88
An Update on Molecular Diagnostics for COVID-1987
Gut Microbiota Status in COVID-19: An Unrecognized Player?86
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review85
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation83
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy83
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial82
Proteus mirabilis Biofilm: Development and Therapeutic Strategies82
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection80
Viral Infections, the Microbiome, and Probiotics79
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic77
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium77
Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases77
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy76
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review75
An Overview of Anti-Eukaryotic T6SS Effectors75
Herpes Simplex Virus Cell Entry Mechanisms: An Update74
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome73
How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches73
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples72
The Impact of Gut Microbiota on Radiation-Induced Enteritis70
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility70
The Microbiota of the Human Mammary Ecosystem68
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection68
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future67
Bacterial Vaginosis: What Do We Currently Know?66
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota65
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing65
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area65
Cutaneous Malassezia: Commensal, Pathogen, or Protector?65
0.75548005104065